HART IPO Set For Early April, Harvard Bioscience To Spin Off Remaining 83% Stake In 120 Days

By |
0 Comment
In December, Harvard Bioscience(HBIO) filed for an IPO of Harvard Apparatus Regenerative Technologies(HART). Last week, the company announced that the tax free spinoff was approved by the IRS, and that an IPO of 17% of the company would be conducted in early April at an expected price of $10-$12 per share. The company will spin off the remaining 83% to shareholders 120 days after the offering closes.

Disclosure: The author holds no position in any stock mentioned

Related articles

To respond on your own website, enter the URL of your response which should contain a link to this post's permalink URL. Your response will then appear (possibly after moderation) on this page. Want to update or remove your response? Update or delete your post and re-enter your post's URL again. (Find out more about Webmentions.)